Kathy Giusti, of New Canaan, will become the executive chairman of the Multiple Myeloma Research Foundation board of directors. Giusti is the founder and CEO of the MMRF and the Multiple Myeloma Research Consortium.
According to Giusti, the MMRF is entering a new era of transformational change in treating cancer.
"As we participate in the global cancer research platform," she said in a news release, "we are very excited to be collaborators in developing opportunities that strengthen and speed our quest for a cure. We see new hope every day as we share big data to drive discovery and pursue innovative approaches in immune therapy, targeted drugs and trial design. I look forward to my new role that allows me to continue to support our commitment to myeloma patients, focus on expanding critical corporate partnerships, and launch the largest capital campaign in the company's history."
The foundation attributes its success over the past 16 years to the work of innovative people, according to the release. Capone has helped build a team that demonstrates the MMRF's core values. He will take on new initiatives and align with new partners.
Giusti said she believes there is still much to do, but the new leadership structure will continue to strengthen and speed the quest for a cure for multiple myeloma.
"When I contemplate our accomplishments over the last 16 years," she said, "I am filled with the pride of all those involved in our legacy. I am grateful for our talented team, our outstanding collaborators and the courageous patients who inspire us every day. Together, we have made tremendous advances in extending patients' lives, while accelerating a cure for multiple myeloma."
The MMRF was established by Giusti and her sister, Karen Andrews, soon after Giusti's diagnosis with multiple myeloma.
For information, visit www.themmrf.org.